NEXTBLUE is a Tokyo-based early-stage venture capital firm and Asia's first fund dedicated to empowering female founders in women's wellbeing. It invests in pre-seed, seed, and pre-Series A startups in Japan, the US, and Europe, focusing on Femtech, healthtech, consumer, and food sectors.
38% of their portfolio is in Healthcare. Average disclosed round size is $991.1M (across 6 rounds with reported amounts).
Portfolio
8
Fund Size
$40M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Eli Health | Series A | $17M | Jun 2025 |
 Trellis | Pre-Seed | $15M | Jan 2023 |
 kencko | Series A | $10M | Jan 2022 |
 INFORICH | Unknown | $5.9B | Jan 2021 |
 Sage Haven | Pre-Seed | $3M | — |
| Bbgrass | Series A | — | — |
 Trellis Health | Pre-Seed | $1.8M | — |
 Anise Health | Seed | — | — |
Top Co-Investors
Swizzle Ventures3 shared
Arthur Ventures1 shared
NextView Ventures1 shared
Indico Capital Partners1 shared
Silas Capital1 shared
Shilling Capital Partners1 shared
Cheyenne Ventures1 shared
Siddhi Capital1 shared
Riverside Ventures1 shared
Gaingels1 shared
Fuel Ventures1 shared
Hustle Fund1 shared
Graham & Walker1 shared
CyberAgent Capital1 shared
The Goldman Sachs Group, Inc.1 shared
JAPAN POST CAPITAL Co., Ltd.1 shared
Real Ventures1 shared
TELUS Global Ventures1 shared
Muse Capital1 shared
Last updated: 20 October 2026